216 related articles for article (PubMed ID: 19446588)
21. BK-VP3 as a new target of cellular immunity in BK virus infection.
Mueller K; Schachtner T; Sattler A; Meier S; Friedrich P; Trydzenskaya H; Hinrichs C; Trappe R; Thiel A; Reinke P; Babel N
Transplantation; 2011 Jan; 91(1):100-7. PubMed ID: 21452414
[TBL] [Abstract][Full Text] [Related]
22. Polyomavirus infection and its impact on renal function and long-term outcomes after lung transplantation.
Thomas LD; Milstone AP; Vilchez RA; Zanwar P; Butel JS; Dummer JS
Transplantation; 2009 Aug; 88(3):360-6. PubMed ID: 19667938
[TBL] [Abstract][Full Text] [Related]
23. An immunoinformatic approach to universal therapeutic vaccine design against BK virus.
Kesherwani V; Tarang S
Vaccine; 2019 Jun; 37(26):3457-3463. PubMed ID: 31097352
[TBL] [Abstract][Full Text] [Related]
24. Genotypic diversity of polyomaviruses circulating among kidney transplant recipients in Kuwait.
Chehadeh W; Nampoory MR
J Med Virol; 2013 Sep; 85(9):1624-31. PubMed ID: 23775307
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of HLA-A*0301 epitopes in HIV-1 gag proteins using a novel approach.
Semeniuk CA; Capina RE; Mendoza MG; Kimani J; Ball TB; Luo M; Plummer FA
J Immunol Methods; 2010 Jan; 352(1-2):118-25. PubMed ID: 19903485
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T lymphocyte recognition sequences as markers for distinguishing among tumour antigens encoded by SV40, BKV and JCV.
Tevethia SS; Mylin L; Newmaster R; Epler M; Lednicky JA; Butel JS; Tevethia MJ
Dev Biol Stand; 1998; 94():329-39. PubMed ID: 9776254
[TBL] [Abstract][Full Text] [Related]
27. Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant.
Schneidawind D; Schmitt A; Wiesneth M; Mertens T; Bunjes D; Freund M; Schmitt M
Leuk Lymphoma; 2010 Jun; 51(6):1055-62. PubMed ID: 20370539
[TBL] [Abstract][Full Text] [Related]
28. CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation.
Fan Y; Bai H; Qian Y; Sun Z; Shi B
Surg Infect (Larchmt); 2019 Apr; 20(3):236-243. PubMed ID: 30707648
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a potential human epitope from simian virus 40 large T antigen.
Schell TD; Lippolis JD; Tevethia SS
Cancer Res; 2001 Feb; 61(3):873-9. PubMed ID: 11221873
[TBL] [Abstract][Full Text] [Related]
30. Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.
Randhawa P; Viscidi R; Carter JJ; Galloway DA; Culp TD; Huang C; Ramaswami B; Christensen ND
J Gen Virol; 2009 Mar; 90(Pt 3):634-639. PubMed ID: 19218208
[TBL] [Abstract][Full Text] [Related]
31. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
[TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of BKV-specific CD4+ T cells before and after kidney transplantation.
Mutlu E; Köksoy S; Mutlu D; Yılmaz VT; Koçak H; Dinçkan A; Süleymanlar G; Gültekin M
Transpl Immunol; 2015 Sep; 33(1):20-6. PubMed ID: 26048051
[TBL] [Abstract][Full Text] [Related]
33. Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis.
Prosser SE; Orentas RJ; Jurgens L; Cohen EP; Hariharan S
Transplantation; 2008 Jan; 85(2):185-92. PubMed ID: 18212622
[TBL] [Abstract][Full Text] [Related]
34. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
[TBL] [Abstract][Full Text] [Related]
35. Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.
Canivet C; Rostaing L; Galvani S; Böhler T; Gandia P; Mengelle C; Guilbeau-Frugier C; Thomsen M; Salvayre R; Negre-Salvayre A; Kamar N
Int Immunopharmacol; 2009 Aug; 9(9):1131-6. PubMed ID: 19446045
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory activation and recovering BKV-specific immunity correlate with self-limited BKV replication after renal transplantation.
Schachtner T; Stein M; Sefrin A; Babel N; Reinke P
Transpl Int; 2014 Mar; 27(3):290-301. PubMed ID: 24279642
[TBL] [Abstract][Full Text] [Related]
37. Antigen-Specificity of T Cell Infiltrates in Biopsies With T Cell-Mediated Rejection and BK Polyomavirus Viremia: Analysis by Next Generation Sequencing.
Zeng G; Huang Y; Huang Y; Lyu Z; Lesniak D; Randhawa P
Am J Transplant; 2016 Nov; 16(11):3131-3138. PubMed ID: 27273900
[TBL] [Abstract][Full Text] [Related]
38. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
[TBL] [Abstract][Full Text] [Related]
39. Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.
Peretti A; Geoghegan EM; Pastrana DV; Smola S; Feld P; Sauter M; Lohse S; Ramesh M; Lim ES; Wang D; Borgogna C; FitzGerald PC; Bliskovsky V; Starrett GJ; Law EK; Harris RS; Killian JK; Zhu J; Pineda M; Meltzer PS; Boldorini R; Gariglio M; Buck CB
Cell Host Microbe; 2018 May; 23(5):628-635.e7. PubMed ID: 29746834
[TBL] [Abstract][Full Text] [Related]
40. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation.
Mani J; Jin N; Schmitt M
Cytotherapy; 2014 Oct; 16(10):1325-35. PubMed ID: 24934303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
